#METABOLOMICS WORKBENCH stephensondj_20230908_115906 DATATRACK_ID:4299 STUDY_ID:ST002857 ANALYSIS_ID:AN004683
VERSION                          	1
CREATED_ON                       	09-13-2023
#PROJECT
PR:PROJECT_TITLE                 	Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells
PR:PROJECT_TITLE                 	in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I
PR:PROJECT_TITLE                 	dose-escalation clinical trial
PR:PROJECT_TYPE                  	MS untargeted analysis
PR:PROJECT_SUMMARY               	SUMMARY This is an open-label, first-in-human, dose-escalation phase I study
PR:PROJECT_SUMMARY               	(NCT03282760, EudraCT2015‐004855‐37) to determine the feasibility, safety,
PR:PROJECT_SUMMARY               	and tolerability of the transplantation of allogeneic human neural
PR:PROJECT_SUMMARY               	stem/progenitor cells (hNSCs) for the treatment of progressive multiple
PR:PROJECT_SUMMARY               	sclerosis. We report the analysis of 1 year of data from the first cohort of 15
PR:PROJECT_SUMMARY               	patients from two trial sites that received increasing numbers of allogeneic
PR:PROJECT_SUMMARY               	hNSCs delivered via intracerebroventricular injection in combination with an
PR:PROJECT_SUMMARY               	immunosuppressive regimen. No treatment-related deaths nor serious adverse
PR:PROJECT_SUMMARY               	events (AEs) were observed over the 12-month follow-up. Participants displayed
PR:PROJECT_SUMMARY               	stability of clinical and laboratory parameters, as well as lesion load and
PR:PROJECT_SUMMARY               	activity at the brain MRIs, compared to study entry. Longitudinal metabolomics
PR:PROJECT_SUMMARY               	and lipidomics analyses of cerebrospinal fluid and serum from these patients
PR:PROJECT_SUMMARY               	identified time and dose-dependent responses, with increased levels of free
PR:PROJECT_SUMMARY               	fatty acids and acylcarnitines in the CSF, especially at the highest dose of
PR:PROJECT_SUMMARY               	injected hNSCs at the one-year follow-up time point. Finally, a significant
PR:PROJECT_SUMMARY               	inverse correlation was found between the highest dose of injected hNSCs and the
PR:PROJECT_SUMMARY               	smaller parenchymal brain volume change (PBVC; Spearman’s rho= -0.7, p= 0.03),
PR:PROJECT_SUMMARY               	clinical covariates that correlated with CSF levels of free fatty acids,
PR:PROJECT_SUMMARY               	acyl-carnitines, oxylipins, conjugated bile acids and purine breakdown and
PR:PROJECT_SUMMARY               	deamination products, such as hypoxanthine. The absence of AEs and the stability
PR:PROJECT_SUMMARY               	of functional and structural outcomes is reassuring in terms of risks and
PR:PROJECT_SUMMARY               	represent a main milestone to rigorously address the challenges for the safe
PR:PROJECT_SUMMARY               	translation of key principles of stem cell biology into effective regenerative
PR:PROJECT_SUMMARY               	medicines.  
PR:INSTITUTE                     	University of Colorado
PR:DEPARTMENT                    	Department of Biochemistry and Molecular Genetics
PR:LABORATORY                    	Angelo D’Alessandro
PR:LAST_NAME                     	Stephenson
PR:FIRST_NAME                    	Daniel
PR:ADDRESS                       	Research 1 South L18-1303 12801 E. 17th Ave., Aurora, Colorado, 80045, USA
PR:EMAIL                         	daniel.stephenson@cuanschutz.edu
PR:PHONE                         	303-724-3339
PR:DOI                           	http://dx.doi.org/10.21228/M8G43R
#STUDY
ST:STUDY_TITLE                   	Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells
ST:STUDY_TITLE                   	in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I
ST:STUDY_TITLE                   	dose-escalation clinical trial - Metabolomics Analysis of Human CSF
ST:STUDY_SUMMARY                 	This is an open-label, first-in-human, dose-escalation phase I study
ST:STUDY_SUMMARY                 	(NCT03282760, EudraCT2015‐004855‐37) to determine the feasibility, safety,
ST:STUDY_SUMMARY                 	and tolerability of the transplantation of allogeneic human neural
ST:STUDY_SUMMARY                 	stem/progenitor cells (hNSCs) for the treatment of progressive multiple
ST:STUDY_SUMMARY                 	sclerosis. We report the analysis of 1 year of data from the first cohort of 15
ST:STUDY_SUMMARY                 	patients from two trial sites that received increasing numbers of allogeneic
ST:STUDY_SUMMARY                 	hNSCs delivered via intracerebroventricular injection in combination with an
ST:STUDY_SUMMARY                 	immunosuppressive regimen. No treatment-related deaths nor serious adverse
ST:STUDY_SUMMARY                 	events (AEs) were observed over the 12-month follow-up. Participants displayed
ST:STUDY_SUMMARY                 	stability of clinical and laboratory parameters, as well as lesion load and
ST:STUDY_SUMMARY                 	activity at the brain MRIs, compared to study entry. Longitudinal metabolomics
ST:STUDY_SUMMARY                 	and lipidomics analyses of cerebrospinal fluid and serum from these patients
ST:STUDY_SUMMARY                 	identified time and dose-dependent responses, with increased levels of free
ST:STUDY_SUMMARY                 	fatty acids and acylcarnitines in the CSF, especially at the highest dose of
ST:STUDY_SUMMARY                 	injected hNSCs at the one-year follow-up time point. Finally, a significant
ST:STUDY_SUMMARY                 	inverse correlation was found between the highest dose of injected hNSCs and the
ST:STUDY_SUMMARY                 	smaller parenchymal brain volume change (PBVC; Spearman’s rho= -0.7, p= 0.03),
ST:STUDY_SUMMARY                 	clinical covariates that correlated with CSF levels of free fatty acids,
ST:STUDY_SUMMARY                 	acyl-carnitines, oxylipins, conjugated bile acids and purine breakdown and
ST:STUDY_SUMMARY                 	deamination products, such as hypoxanthine. The absence of AEs and the stability
ST:STUDY_SUMMARY                 	of functional and structural outcomes is reassuring in terms of risks and
ST:STUDY_SUMMARY                 	represent a main milestone to rigorously address the challenges for the safe
ST:STUDY_SUMMARY                 	translation of key principles of stem cell biology into effective regenerative
ST:STUDY_SUMMARY                 	medicines.
ST:INSTITUTE                     	University of Colorado
ST:DEPARTMENT                    	Department of Biochemistry and Molecular Genetics
ST:LABORATORY                    	Angelo D’Alessandro
ST:LAST_NAME                     	Stephenson
ST:FIRST_NAME                    	Daniel
ST:ADDRESS                       	Research 1 South L18-1303 12801 E. 17th Ave., Aurora, Colorado, 80045, USA
ST:EMAIL                         	daniel.stephenson@cuanschutz.edu
ST:PHONE                         	303-724-3339
ST:SUBMIT_DATE                   	2023-09-08
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
SU:GENDER                        	Male and female
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	1151	DS1-123-005	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-005+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-005-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-005+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-005-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-005-neg_oxylipinsCSF.mzXML; ID=1
SUBJECT_SAMPLE_FACTORS           	1219	DS1-123-032	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-032+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-032-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-032+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-032-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-032-neg_oxylipinsCSF.mzXML; ID=2
SUBJECT_SAMPLE_FACTORS           	1249	DS1-123-035	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-035+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-035-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-035+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-035-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-035-neg_oxylipinsCSF.mzXML; ID=3
SUBJECT_SAMPLE_FACTORS           	1289	DS1-123-046	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-046+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-046-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-046+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-046-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-046-neg_oxylipinsCSF.mzXML; ID=4
SUBJECT_SAMPLE_FACTORS           	1323	DS1-123-057	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-057+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-057-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-057+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-057-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-057-neg_oxylipinsCSF.mzXML; ID=5
SUBJECT_SAMPLE_FACTORS           	1252	DS1-123-070	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-070+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-070-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-070+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-070-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-070-neg_oxylipinsCSF.mzXML; ID=6
SUBJECT_SAMPLE_FACTORS           	1243	DS1-123-072	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-072+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-072-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-072+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-072-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-072-neg_oxylipinsCSF.mzXML; ID=7
SUBJECT_SAMPLE_FACTORS           	1210	DS1-123-094	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-094+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-094-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-094+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-094-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-094-neg_oxylipinsCSF.mzXML; ID=8
SUBJECT_SAMPLE_FACTORS           	1181	DS1-123-100	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-100+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-100-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-100+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-100-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-100-neg_oxylipinsCSF.mzXML; ID=9
SUBJECT_SAMPLE_FACTORS           	1194	DS1-123-103	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-103+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-103-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-103+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-103-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-103-neg_oxylipinsCSF.mzXML; ID=10
SUBJECT_SAMPLE_FACTORS           	1296	DS1-123-125	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-125+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-125-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-125+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-125-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-125-neg_oxylipinsCSF.mzXML; ID=11
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-134	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-134+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-134-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-134+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-134-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-134-neg_oxylipinsCSF.mzXML; ID=12
SUBJECT_SAMPLE_FACTORS           	1296	DS1-123-139	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-139+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-139-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-139+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-139-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-139-neg_oxylipinsCSF.mzXML; ID=13
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-146	TimeGroup:FU1	RAW_FILE_NAME=DS1-123-146+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-146-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-146+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-146-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-146-neg_oxylipinsCSF.mzXML; ID=14
SUBJECT_SAMPLE_FACTORS           	1151	DS1-123-027	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-027+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-027-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-027+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-027-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-027-neg_oxylipinsCSF.mzXML; ID=15
SUBJECT_SAMPLE_FACTORS           	1178	DS1-123-031	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-031+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-031-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-031+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-031-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-031-neg_oxylipinsCSF.mzXML; ID=16
SUBJECT_SAMPLE_FACTORS           	1249	DS1-123-058	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-058+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-058-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-058+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-058-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-058-neg_oxylipinsCSF.mzXML; ID=17
SUBJECT_SAMPLE_FACTORS           	1289	DS1-123-063	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-063+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-063-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-063+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-063-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-063-neg_oxylipinsCSF.mzXML; ID=18
SUBJECT_SAMPLE_FACTORS           	1210	DS1-123-073	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-073+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-073-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-073+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-073-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-073-neg_oxylipinsCSF.mzXML; ID=19
SUBJECT_SAMPLE_FACTORS           	1194	DS1-123-093	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-093+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-093-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-093+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-093-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-093-neg_oxylipinsCSF.mzXML; ID=20
SUBJECT_SAMPLE_FACTORS           	1181	DS1-123-111	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-111+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-111-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-111+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-111-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-111-neg_oxylipinsCSF.mzXML; ID=21
SUBJECT_SAMPLE_FACTORS           	1323	DS1-123-124	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-124+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-124-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-124+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-124-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-124-neg_oxylipinsCSF.mzXML; ID=22
SUBJECT_SAMPLE_FACTORS           	1252	DS1-123-136	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-136+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-136-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-136+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-136-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-136-neg_oxylipinsCSF.mzXML; ID=23
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-148	TimeGroup:FU12	RAW_FILE_NAME=DS1-123-148+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-148-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-148+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-148-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-148-neg_oxylipinsCSF.mzXML; ID=24
SUBJECT_SAMPLE_FACTORS           	1151	DS1-123-011	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-011+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-011-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-011+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-011-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-011-neg_oxylipinsCSF.mzXML; ID=25
SUBJECT_SAMPLE_FACTORS           	1178	DS1-123-018	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-018+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-018-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-018+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-018-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-018-neg_oxylipinsCSF.mzXML; ID=26
SUBJECT_SAMPLE_FACTORS           	1228	DS1-123-037	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-037+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-037-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-037+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-037-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-037-neg_oxylipinsCSF.mzXML; ID=27
SUBJECT_SAMPLE_FACTORS           	1249	DS1-123-043	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-043+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-043-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-043+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-043-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-043-neg_oxylipinsCSF.mzXML; ID=28
SUBJECT_SAMPLE_FACTORS           	1194	DS1-123-080	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-080+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-080-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-080+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-080-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-080-neg_oxylipinsCSF.mzXML; ID=29
SUBJECT_SAMPLE_FACTORS           	1210	DS1-123-083	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-083+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-083-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-083+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-083-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-083-neg_oxylipinsCSF.mzXML; ID=30
SUBJECT_SAMPLE_FACTORS           	1181	DS1-123-105	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-105+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-105-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-105+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-105-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-105-neg_oxylipinsCSF.mzXML; ID=31
SUBJECT_SAMPLE_FACTORS           	1252	DS1-123-127	TimeGroup:FU6	RAW_FILE_NAME=DS1-123-127+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-127-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-127+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-127-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-127-neg_oxylipinsCSF.mzXML; ID=32
SUBJECT_SAMPLE_FACTORS           	1178	DS1-123-007	TimeGroup:REND	RAW_FILE_NAME=DS1-123-007+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-007-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-007+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-007-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-007-neg_oxylipinsCSF.mzXML; ID=33
SUBJECT_SAMPLE_FACTORS           	1228	DS1-123-021	TimeGroup:REND	RAW_FILE_NAME=DS1-123-021+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-021-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-021+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-021-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-021-neg_oxylipinsCSF.mzXML; ID=34
SUBJECT_SAMPLE_FACTORS           	1249	DS1-123-028	TimeGroup:REND	RAW_FILE_NAME=DS1-123-028+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-028-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-028+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-028-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-028-neg_oxylipinsCSF.mzXML; ID=35
SUBJECT_SAMPLE_FACTORS           	1289	DS1-123-042	TimeGroup:REND	RAW_FILE_NAME=DS1-123-042+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-042-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-042+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-042-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-042-neg_oxylipinsCSF.mzXML; ID=36
SUBJECT_SAMPLE_FACTORS           	1316	DS1-123-050	TimeGroup:REND	RAW_FILE_NAME=DS1-123-050+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-050-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-050+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-050-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-050-neg_oxylipinsCSF.mzXML; ID=37
SUBJECT_SAMPLE_FACTORS           	1151	DS1-123-071	TimeGroup:REND	RAW_FILE_NAME=DS1-123-071+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-071-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-071+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-071-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-071-neg_oxylipinsCSF.mzXML; ID=38
SUBJECT_SAMPLE_FACTORS           	1252	DS1-123-087	TimeGroup:REND	RAW_FILE_NAME=DS1-123-087+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-087-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-087+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-087-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-087-neg_oxylipinsCSF.mzXML; ID=39
SUBJECT_SAMPLE_FACTORS           	1210	DS1-123-102	TimeGroup:REND	RAW_FILE_NAME=DS1-123-102+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-102-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-102+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-102-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-102-neg_oxylipinsCSF.mzXML; ID=40
SUBJECT_SAMPLE_FACTORS           	1194	DS1-123-106	TimeGroup:REND	RAW_FILE_NAME=DS1-123-106+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-106-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-106+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-106-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-106-neg_oxylipinsCSF.mzXML; ID=41
SUBJECT_SAMPLE_FACTORS           	1181	DS1-123-116	TimeGroup:REND	RAW_FILE_NAME=DS1-123-116+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-116-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-116+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-116-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-116-neg_oxylipinsCSF.mzXML; ID=42
SUBJECT_SAMPLE_FACTORS           	1243	DS1-123-117	TimeGroup:REND	RAW_FILE_NAME=DS1-123-117+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-117-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-117+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-117-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-117-neg_oxylipinsCSF.mzXML; ID=43
SUBJECT_SAMPLE_FACTORS           	1296	DS1-123-123	TimeGroup:REND	RAW_FILE_NAME=DS1-123-123+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-123-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-123+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-123-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-123-neg_oxylipinsCSF.mzXML; ID=44
SUBJECT_SAMPLE_FACTORS           	1323	DS1-123-131	TimeGroup:REND	RAW_FILE_NAME=DS1-123-131+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-131-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-131+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-131-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-131-neg_oxylipinsCSF.mzXML; ID=45
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-133	TimeGroup:REND	RAW_FILE_NAME=DS1-123-133+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-133-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-133+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-133-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-133-neg_oxylipinsCSF.mzXML; ID=46
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-145	TimeGroup:REND	RAW_FILE_NAME=DS1-123-145+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-145-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-145+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-145-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-145-neg_oxylipinsCSF.mzXML; ID=47
SUBJECT_SAMPLE_FACTORS           	1151	DS1-123-001	TimeGroup:START	RAW_FILE_NAME=DS1-123-001+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-001-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-001+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-001-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-001-neg_oxylipinsCSF.mzXML; ID=48
SUBJECT_SAMPLE_FACTORS           	1178	DS1-123-003	TimeGroup:START	RAW_FILE_NAME=DS1-123-003+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-003-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-003+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-003-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-003-neg_oxylipinsCSF.mzXML; ID=49
SUBJECT_SAMPLE_FACTORS           	1219	DS1-123-014	TimeGroup:START	RAW_FILE_NAME=DS1-123-014+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-014-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-014+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-014-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-014-neg_oxylipinsCSF.mzXML; ID=50
SUBJECT_SAMPLE_FACTORS           	1228	DS1-123-015	TimeGroup:START	RAW_FILE_NAME=DS1-123-015+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-015-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-015+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-015-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-015-neg_oxylipinsCSF.mzXML; ID=51
SUBJECT_SAMPLE_FACTORS           	1249	DS1-123-025	TimeGroup:START	RAW_FILE_NAME=DS1-123-025+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-025-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-025+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-025-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-025-neg_oxylipinsCSF.mzXML; ID=52
SUBJECT_SAMPLE_FACTORS           	1289	DS1-123-039	TimeGroup:START	RAW_FILE_NAME=DS1-123-039+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-039-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-039+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-039-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-039-neg_oxylipinsCSF.mzXML; ID=53
SUBJECT_SAMPLE_FACTORS           	1323	DS1-123-051	TimeGroup:START	RAW_FILE_NAME=DS1-123-051+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-051-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-051+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-051-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-051-neg_oxylipinsCSF.mzXML; ID=54
SUBJECT_SAMPLE_FACTORS           	1210	DS1-123-076	TimeGroup:START	RAW_FILE_NAME=DS1-123-076+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-076-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-076+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-076-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-076-neg_oxylipinsCSF.mzXML; ID=55
SUBJECT_SAMPLE_FACTORS           	1252	DS1-123-081	TimeGroup:START	RAW_FILE_NAME=DS1-123-081+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-081-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-081+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-081-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-081-neg_oxylipinsCSF.mzXML; ID=56
SUBJECT_SAMPLE_FACTORS           	1296	DS1-123-085	TimeGroup:START	RAW_FILE_NAME=DS1-123-085+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-085-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-085+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-085-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-085-neg_oxylipinsCSF.mzXML; ID=57
SUBJECT_SAMPLE_FACTORS           	1181	DS1-123-099	TimeGroup:START	RAW_FILE_NAME=DS1-123-099+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-099-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-099+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-099-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-099-neg_oxylipinsCSF.mzXML; ID=58
SUBJECT_SAMPLE_FACTORS           	1243	DS1-123-109	TimeGroup:START	RAW_FILE_NAME=DS1-123-109+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-109-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-109+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-109-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-109-neg_oxylipinsCSF.mzXML; ID=59
SUBJECT_SAMPLE_FACTORS           	1194	DS1-123-114	TimeGroup:START	RAW_FILE_NAME=DS1-123-114+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-114-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-114+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-114-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-114-neg_oxylipinsCSF.mzXML; ID=60
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-130	TimeGroup:START	RAW_FILE_NAME=DS1-123-130+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-130-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-130+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-130-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-130-neg_oxylipinsCSF.mzXML; ID=61
SUBJECT_SAMPLE_FACTORS           	1326	DS1-123-142	TimeGroup:START	RAW_FILE_NAME=DS1-123-142+pos_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-142-neg_metabolomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-142+pos_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-142-neg_lipidomicsCSF.mzXML; RAW_FILE_NAME=DS1-123-142-neg_oxylipinsCSF.mzXML; ID=62
#COLLECTION
CO:COLLECTION_SUMMARY            	lumbar puncture for serum and CSF collection (stored at -80°C)
CO:SAMPLE_TYPE                   	CSF
#TREATMENT
TR:TREATMENT_SUMMARY             	A total of 180 candidates volunteered between September 26, 2017, and January
TR:TREATMENT_SUMMARY             	13, 2020. The study was conducted in three centers. Two Italian centers, the
TR:TREATMENT_SUMMARY             	‘IRCCS Casa Sollievo della Sofferenza’ Research Hospital (Site 1) and the
TR:TREATMENT_SUMMARY             	‘Santa Maria di Terni’ Hospital (Site 2) recruited patients and performed
TR:TREATMENT_SUMMARY             	the MRI examinations. The Multiple Sclerosis Centre of the Neurocentre of
TR:TREATMENT_SUMMARY             	Southern Switzerland (Site 3) performed the magnetic resonance imaging (MRI)
TR:TREATMENT_SUMMARY             	analysis. The ICVI of the ACT was performed at Site 2. Screening was done one
TR:TREATMENT_SUMMARY             	month prior to enrolment in the study. The run-in period started after the
TR:TREATMENT_SUMMARY             	screening examination (Run-in-START) and lasted three months (Run-in-END). After
TR:TREATMENT_SUMMARY             	screening in the two recruiting centers (as above), n= 15 subjects with active
TR:TREATMENT_SUMMARY             	and non-active SPMS suffering from progressive disability were found to be
TR:TREATMENT_SUMMARY             	eligible, consented, and were assigned a unique identification number.
TR:TREATMENT_SUMMARY             	Participants, nine females and six males, had a mean age of 50 years (range:
TR:TREATMENT_SUMMARY             	38–57), and were recruited in similar proportions by the two study sites. The
TR:TREATMENT_SUMMARY             	mean EDSS was 7.6 (range 7–8), mean disease duration was 23 years (range
TR:TREATMENT_SUMMARY             	14–30), and mean time from diagnosis to secondary progression was 10 years
TR:TREATMENT_SUMMARY             	(range: 1–20). The hNSC-SPMS study was advertised using the website of the
TR:TREATMENT_SUMMARY             	hospitals and social media (eg Facebook and Twitter). The first patient
TR:TREATMENT_SUMMARY             	selection was performed based on the documentation provided. Selected patients
TR:TREATMENT_SUMMARY             	were then summoned in Site 1 and Site 2 (as above) for a first pre-screening
TR:TREATMENT_SUMMARY             	meeting with the clinicians. Patients who agreed to participate were then
TR:TREATMENT_SUMMARY             	subjected to the screening visit for the clinical trial. Following the surgical
TR:TREATMENT_SUMMARY             	procedure, follow-up visits were performed monthly up to 12 months. Before
TR:TREATMENT_SUMMARY             	transplantation, all patients underwent the following examinations (at both
TR:TREATMENT_SUMMARY             	Run-in-START and Run-in-END): physical and neurological exams; vital signs;
TR:TREATMENT_SUMMARY             	pregnancy tests (in fertile women); haematological and urine tests; lumbar
TR:TREATMENT_SUMMARY             	puncture for serum and CSF collection (stored at -80°C);
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Extraction of metabolites and lipids from serum and cerebrospinal fluid (CSF)
SP:SAMPLEPREP_SUMMARY            	was as follows: 40 µL CSF or serum was aliquoted into 2mL deep well plates
SP:SAMPLEPREP_SUMMARY            	followed by an addition of 360 µL cold MeOH:MeCN:H2O (5:3:2, v:v:v). Plates
SP:SAMPLEPREP_SUMMARY            	were then placed on a shaker at 4°C and plate shaker was set to 400 RPM for 30
SP:SAMPLEPREP_SUMMARY            	minutes. Insoluble material was pelleted by centrifugation (4000 RPM, 10 min)
SP:SAMPLEPREP_SUMMARY            	and supernatants were isolated for analysis by UHPLC-MS. All 96-well plate
SP:SAMPLEPREP_SUMMARY            	pipetting was done using Integra MINI 96 (Integra Biosciences).
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	Oxylipin Method
CH:INSTRUMENT_NAME               	Thermo Vanquish
CH:COLUMN_NAME                   	Waters ACQUITY UPLC BEH C18 (100 x 2.1mm,1.7um)
CH:COLUMN_TEMPERATURE            	60
CH:FLOW_GRADIENT                 	0min - 0.35ml/min - 0%B, 0.5min - 0.35ml/min - 25%B, 1min - 0.35ml/min - 25%B,
CH:FLOW_GRADIENT                 	2.5min - 0.35ml/min 40%B, 2.6min -0.35ml/min 55%B, 4.5min - 0.35ml/min - 70%B,
CH:FLOW_GRADIENT                 	4.6min - 0.35ml/min - 100%B, 6min - 0.35ml/min - 100%B, 6.1min - 0.35ml/min -
CH:FLOW_GRADIENT                 	0%B, 7min - 0.35ml/min 0%B
CH:FLOW_RATE                     	.35ml/min
CH:SOLVENT_A                     	20:80:0.02 ACN:Water:Formic Acid
CH:SOLVENT_B                     	20:80:0.02 ACN:IPA:Formic Acid
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:MS_COMMENTS                   	Software for Feature Assignments - El-Maven
MS:ION_MODE                      	NEGATIVE
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS         	Peak area
MS_METABOLITE_DATA_START
Samples	DS1-123-005	DS1-123-032	DS1-123-035	DS1-123-046	DS1-123-057	DS1-123-070	DS1-123-072	DS1-123-094	DS1-123-100	DS1-123-103	DS1-123-125	DS1-123-134	DS1-123-139	DS1-123-146	DS1-123-027	DS1-123-031	DS1-123-058	DS1-123-063	DS1-123-073	DS1-123-093	DS1-123-111	DS1-123-124	DS1-123-136	DS1-123-148	DS1-123-011	DS1-123-018	DS1-123-037	DS1-123-043	DS1-123-080	DS1-123-083	DS1-123-105	DS1-123-127	DS1-123-007	DS1-123-021	DS1-123-028	DS1-123-042	DS1-123-050	DS1-123-071	DS1-123-087	DS1-123-102	DS1-123-106	DS1-123-116	DS1-123-117	DS1-123-123	DS1-123-131	DS1-123-133	DS1-123-145	DS1-123-001	DS1-123-003	DS1-123-014	DS1-123-015	DS1-123-025	DS1-123-039	DS1-123-051	DS1-123-076	DS1-123-081	DS1-123-085	DS1-123-099	DS1-123-109	DS1-123-114	DS1-123-130	DS1-123-142
Factors	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU1	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU12	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:FU6	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:REND	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	TimeGroup:START	
12(13)-DiHOME	31788.9000	32932.2900	31721.1300	29210.3300	31527.6400	50457.8800	38747.1300	35676.8400	30211.7500	56906.5300	33742.5700	35142.6500	40643.9800	32613.9800	32493.9400	30550.4100	39099.7000	29079.4900	39289.5300	35481.5800	38334.9200	31661.7700	34492.1800	52211.5200	29718.3900	35377.7700	35066.4100	31005.4600	38311.7800	36344.0600	39119.3500	46904.3900	29233.7800	33969.6100	31884.8200	32535.1900	33029.9000	34489.6400	46430.3900	37344.0200	37348.7100	33065.0000	43671.8700	34547.7300	35989.0700	38584.8400	38871.4100	29890.3300	28049.9100	29530.2000	31374.4800	29712.8500	33748.1800	31923.7300	34986.4300	33676.0600	43301.9200	46073.8700	42846.8800	31848.5700	30067.0000	35570.7400
12(S)-HETE													15038.7400				88682.1000	1416.8600					3877.1400	7177.8100			1145.9900		990.7300									1015.1200					1810.0400	101670.3800									1141.9300							4111.3800		8492.7100
13-14-dihydro-15-keto Prostaglandin D2	784.0100	1177.9100	2399.5500	1038.6900		2617.2400	1199.4500	1455.5600		3087.6800	2531.8000	1769.2900	1202.0600	1636.5100	1504.1700	873.7500	5710.7600	795.6500	1704.0500	2262.8800	1461.7000	1922.8600	988.1000	1199.2200	2512.4900	997.2100	2723.9200	1586.9100	1015.4700	1472.5800	866.3400	957.1000	1006.9300	1506.4400	1247.6900	3749.1100	1153.5500	1384.3400	1807.0900	931.6500	1161.1900	2054.2300	1718.3400	2637.8900	1152.4600	1986.1100	2736.7800	1873.1800		3075.7100		1174.7300	1263.2200	1014.1100	1279.3800	1906.4500	1427.9000	2098.9900	1113.5000		1117.6500	
13-OxoODE	10947.5500	6467.1800	8568.6300	5052.2200	6450.7100	8296.3200	3916.9900	6494.5000	7414.5100	11469.2700	5973.5200	11925.1600	9946.4700	7746.7200	11790.5800	5210.9000	7991.0400	7638.1800	9268.6700	3753.6300	4243.0600	6960.4700	7508.5100	6209.3500	4829.1700	8591.9700	2849.5100	7228.7200	8815.1800	6037.9800	8351.3700	13596.7200	4543.4400	3474.9500	4859.9600	3506.9400	10684.2400	7262.3000	7740.1900	8139.9800	7722.2000	5224.7900	8938.2600	6102.8900	10690.8600	8005.7000	11224.4300	5335.1100	6081.5900	6258.0300	4799.8600	5999.0800	7557.5900	3724.4100	3815.1900	8175.8100	8438.3500	6931.6000	9557.1000	5238.9400	9333.6400	17173.0900
13(S)-HODE	29635.7400	8896.5800	16665.3500	16072.0600	12509.9300	18192.8100	13605.8600	14267.4900	13084.3600	15959.4300	15490.1300	15178.4100	20376.6000	17607.6900	16905.3300	13617.7500	23255.4900	14067.1600	16354.5000	14434.2300	12980.3800	16163.0400	19727.4000	22020.5800	11447.1600	15333.7700	17288.0900	15619.8100	22332.7900	14129.4300	18592.0900	25380.0700	16266.5400	20394.0600	12155.6000	15638.2600	19711.8100	17024.8800	20094.6100	14237.6900	17956.3900	14388.7800	22890.1600	15956.4900	14212.4400	15842.4500	28064.3400	15129.5200	12178.9200	14216.3700	13463.1300	15152.4400	16374.3100	12958.7800	13196.9000	13641.0500	15421.4800	17321.5800	23901.3700	16254.8000	16165.2100	35387.5800
15(S)-HEPE	3086.8500	2467.3900	3605.1100	1702.0700	2515.7200	2770.1400	2034.5300	4365.8900	3832.1800	3615.1600	1924.6600	2012.9100	1489.4300	1460.0700	3797.6800	1892.7500	4527.1200	1527.4600	2345.6300	2027.4300	1853.9800	4481.9500	2341.5900	5260.3600	4883.7600	1365.1200	2923.1500	1429.1000	5348.7900	1864.7900	3581.2600	5446.4300	2888.0400	3579.9700	1431.1500	2010.7100	5210.9400	3420.9000	4375.1300	1524.6800	3556.6000	2909.0800	2020.1000	4466.9700	2656.3200	2620.6300	4148.3600	2473.6600	1704.5800	1482.5800	1580.4800	2482.4600	3547.3500	1544.4800	1727.1000	3283.3900	4602.1200	5295.5100	2430.8400	1498.4700	5103.0700	2091.4400
15(S)-HETE					827.2800												4439.1500																	2262.8400										2546.8100													1197.3100					1150.0100
17(S)-HDHA																																															1339.7500															
5(S)-HETE	988.2600							1411.6500		846.3400					699.8600		983.7800				1023.3500		711.2300	1120.3100						951.4400		916.0600				955.6600					1098.9800	1055.9600	1171.2900	803.1800		758.0300							633.9900	1028.2600						653.0800	1106.3900	727.5200
9(10)-DiHOME	46213.4600	38859.3600	42614.0900	28294.8700	29814.2100	59474.0200	38984.7300	35642.6900	25359.8400	52961.3900	31770.8400	43286.6600	42345.8500	21394.8900	20841.1700	16157.8600	54191.7800	22203.2800	59050.8000	28331.7400	50149.3400	49382.9200	42421.8500	51026.0000	18073.6500	23357.5300	29255.1700	25085.3400	20195.9200	41384.9400	49531.0300	28896.5500	34758.5500	26554.0300	22144.0100	35512.9100	19507.4300	38084.8400	30853.5900	34334.6200	22534.3800	23634.7900	43053.8800	30679.0900	13526.1700	21930.0800	55780.5700	18455.4600	19734.3700	25781.9600	14216.7200	10614.0900	35457.0000	17720.6400	35236.7900	15365.8300	53450.0000	39035.4100	27700.4200	32307.8800	24207.6000	41878.5300
9-OxoODE	7799.8500	4062.6000	6771.7900	3463.2800	3535.8800	2813.4300	3639.3900	6646.8500	6665.6300	9209.3200	5991.6700	11000.1200	8743.5000	7144.8800	14375.8800	3222.6500	7998.5800	4129.8000	6963.2000	8272.8900	5897.7300	8171.9100	4301.3600	10653.3400	4020.6600	5244.3200	3966.1800	4778.0600	5107.2600	4913.5000	8818.0500	18248.7300	6064.5100	7598.7800	4826.5000	7430.5800	5490.7100	8191.3900	7976.6700	6328.5900	8570.5200	7185.0400	8945.6500	5827.1000	10341.8700	9763.7500	8277.1700	6893.9500	2413.1900	3605.7300	4539.8400	4221.7300	5585.0000	4857.6100	5520.5100	4134.3400	8316.7400	6077.3700	13556.4600	7337.2600	9946.7800	24518.3800
9(S)-HODE	14827.4200	8618.4700	15440.9900	7685.5900	10963.0500	15138.0700	11202.8800	14811.9800	11700.4700	15636.6600	11808.5200	12032.0200	21525.4200	15946.5800	12343.1000	10861.8500	13953.2900	9749.5400	15498.8100	11645.0100	14641.6700	13462.1600	12678.8800	17071.2500	9277.6200	13995.1900	15181.8500	14225.9200	13428.1600	7960.6900	16022.4100	22789.3000	7669.6000	15338.2000	10571.2900	13106.6800	12461.8500	8597.6300	12334.0200	11207.9400	10078.8400	11867.4600	10913.8700	13958.7800	12643.3000	11408.3400	15410.1700	12132.2300	9395.1300	14918.3900	11473.2100	9636.9100	17433.0800	11351.0300	9938.7200	11234.9700	13316.7800	11401.1100	15972.1900	8254.4200	15562.6100	22819.9900
a-Linolenic Acid	1479.8200					4041.2300				1071.6800	1007.1700	1017.3000	4975.7100		1060.1100		19527.0800		1029.5500			1631.8000	2068.1300	15111.4100	1217.5400							4232.4100				4373.3500	966.3600		1620.7700	906.6500			11332.4800	6682.6600	4151.6200	764.6100		774.6300	883.7300	1219.5600	977.9200		6214.9600									4276.1300
Arachidic Acid	6761.1200	9017.6200	11526.9600	8077.3400	9724.7700	9298.7900	7375.1900	7273.7200	4102.6900	6118.1700	5985.6600	9767.9900	4530.6600	7121.8900	61847.7500	8135.7500	6766.5300	6264.7500	11020.3000	6542.4000	7449.1200	7548.8500	9232.0000	9226.7100	7817.5600	7239.2000	15272.0300	6760.5100	8899.3400	9343.8200	7648.2200	8992.8500	10483.5700	13591.1100	8834.6600	8150.8200	10801.0900	10443.5000	8073.0400	5692.5600	11609.7500	8238.2800	8873.4200	9591.1700	7982.7200	16483.3900	12958.6300	8429.2700	8424.6000	7046.5800	7485.2600	7517.2800	2467.6600	5786.6500	6828.6500	11808.7000	9190.3000	7228.1800	8645.0400	9998.5800	4491.2600	5314.8800
Arachidonic Acid	81431.6200	35610.3200	131349.8600	72879.4600	168855.6900	237965.0200	147371.4400	52844.4100	84407.2600	304429.5300	83411.5900	69585.5300	366674.5900	47546.2500	82546.4300	73685.3100	1269938.3800	54497.6100	55866.0900	181829.4500	111061.1300	155038.4200	178298.8100	663040.5600	168633.6700	122079.0000	114140.0500	67966.3800	326082.5900	26007.4800	157374.1600	287355.6200	84815.7900	203694.8800	64072.3900	282420.6200	108550.9800	75783.3400	187871.8900	46399.5400	211763.0000	104392.8800	382414.3800	310550.8800	147532.9200	50872.7300	63789.1600	32415.7700	92864.6600	56448.9500	60494.0700	117161.1000	84542.7900	55027.1400	19107.8300	110449.2000	111702.1200	154109.8400	108897.4500	324467.6600	46469.2800	277873.3400
Chenodeoxycholic acid	8717.8600		29477.1400	4127.6700		3080.2800	78045.6300	13325.7800	14394.7500	25485.2300	51662.5000		84342.4900	11638.6000	3423.5300	33368.0500	2601.0800	16307.9500		50523.1400	14233.5000	3449.9200	2436.0700	26260.5300	9251.2400	9873.6900	7668.7900	10258.7100	11491.6500	3056.7700	38519.0000	12093.5200	30009.7700	3844.0300	10012.7900	2034.9500	13373.2700		3288.1000		18486.0000	49856.9900	185251.3300	63440.9600	8905.7400	3757.0600	7815.3900		18621.1900		4626.4300	5114.1800	2208.5000	6448.0000		25039.6000	18445.3100	58747.6700	16528.8700	16013.5600	6471.0700	19094.6700
Cholic acid	38631.2900	2005.8100	39928.6900	15141.6400	6035.8600	2193.9800	67147.3700	15009.9900	21716.0600	19421.3400	80447.4300		139218.6900	1935.2300	4551.2800	35485.0400	19345.3100	14290.7400	1764.6200	19362.2600	12758.4400	4433.6900		18131.1500	15183.5600	18287.9000	17782.3900	23222.0800	14188.2200	2026.1700	32169.8500	8119.0500	52306.4800	17227.9600	45162.5000	8403.8600	10339.6200	1789.3600			12558.6600	43750.0100	366001.1200	115577.1500	10108.9300	3843.9300	1432.9300	4362.1000	33401.7000	2292.8500	12990.8000	21450.2600	4992.6400	8878.5600	3066.0800	4867.2900	69416.8800	45654.4100	16603.4100	15133.2400	3220.5500	10083.9800
Decanoic Acid	6654.0700	6202.8300	11713.3500	5114.5400	4647.4000	8230.4000	6883.7500	6063.1800	5641.4500	15653.8900	5015.3400	7786.0600	11842.5400	5438.8400	6883.8700	7392.8100	21698.7300	7559.3600	7826.8600	12079.3100	7386.8800	5130.0200	8579.0200	19526.8800	9011.2500	10473.0400	6952.0800	8799.6400	13070.8400	5862.6400	6262.1900	11173.3600	10022.8500	9401.7500	9313.4200	8868.0600	9890.4900	8602.5700	10474.5000	5658.2500	10084.6700	7980.9800	9462.9000	12930.4700	7618.1700	5878.8200	9923.7900	6977.1000	10966.0900	9047.3400	6671.2000	10011.7500	12062.2000	6847.4500	5682.4400	7235.5000	8879.7500	8818.0100	7094.0100	13482.0200	6580.4200	8894.7700
Deoxycholic acid	64006.2200	56607.2900	141483.2500	75678.3400	51703.5900	108419.7100	357140.2800	69544.3400	49080.6600	180675.1200	114522.8400	96435.8200	167729.2800	99130.8700	76063.2700	101601.5900	49601.1700	146173.8400	62665.5600	436418.0000	60563.2200	95719.3800	75796.4400	150812.3100	61344.9700	78907.4800	109639.6000	76720.3700	158670.1700	46804.1100	99213.1900	99546.1200	63859.2500	92784.6500	44884.5200	85456.6200	131222.4500	43522.3400	82219.1800	46950.4500	212727.6700	98623.7200	371406.4100	154476.5300	75868.0100	47745.9000	65506.1400	48131.3800	78839.6300	50341.7700	69701.9800	62099.0400	58544.7800	51954.9700	71760.4900	59074.3300	94862.3100	83676.2100	133707.6400	263668.1200	49695.5600	84019.6600
Dihomo-y-Linolenic Acid			10797.2500														2387.0700							1931.9500																			1674.3100																			
Docosahexaenoic Acid	93882.4000	81000.9700	193354.2700	135571.2700	200846.8000	358272.8400	272604.0300	77554.4100	161277.9800	650730.1900	145414.4800	115355.2800	277474.7800	160868.4800	112172.7900	151096.2500	822012.8100	125455.0600	82896.4100	479964.5900	185220.7500	185353.4400	277912.6200	327689.1200	221695.6200	148489.5500	276238.2200	124688.8700	508203.7800	53287.3300	260637.3800	322169.4100	101270.9800	351326.8800	138962.2300	218887.8000	454828.3400	52367.1100	214958.4200	53820.7900	449904.9100	240164.4200	395273.7800	355441.6600	243642.4400	69542.3800	167153.7300	76648.2200	130385.3400	139091.4400	145440.7700	200069.5000	229347.1700	112564.9100	50725.0300	293668.1900	190109.5600	344386.5900	242684.6200	672704.6900	105833.4100	192971.6200
Docosapentaenoic Acid					2224.7600	8004.4800	1615.6600			4404.5600	1321.5000	1093.0000	6954.0000		1859.6000		12570.0000			2814.4700	1333.2100	5521.0200	6665.2900	2131.8200	5324.2600		1892.3200		2357.3000		2091.1000	2049.8300	1622.8900	3798.8600	3645.3200						4479.7200		8653.6500	6321.8000	2738.6000	1560.8400			4133.0500			1976.8100		2557.0400		1945.3200	1655.1100			4811.8800		1305.9000
Eicosapentaenoic Acid	8251.0600	3951.1500	7760.7100	5162.5800	6086.1400	7654.4900	4892.1000	4975.4500	4548.6200	5635.8600	15647.8100	5198.5900	4211.3000	4093.5500	6914.3600	2346.7100	41646.0400	3149.9400	1552.8700	4733.7500	7266.5300	9712.3000	5026.0200	5420.9800	3531.7000	3638.4700	4268.6700	4617.8400	6032.6500	5893.7300	4334.2100	4325.9900	4763.0400	3918.2400	3773.4200	5924.0900	10333.4000	4999.6500	4445.8700	2842.9800	3875.2500	22820.1500	8755.3800	11823.2600	5568.0800	5070.2400	5268.5000	6339.5200	4671.9900	4024.8400	2696.7500	3699.4000	3502.7900	3761.4700	1502.7200	5309.1500	3750.2400	5143.6400	5662.7400	3510.2400	5334.8300	5457.2000
Glycochenodeoxycholic acid	7269.2800		16792.1700	9853.6300	23317.3100	22036.9600	132199.1900	30080.4200	39201.6900	132120.9200	25693.3300	18023.7000	83561.0900	27624.4400	14384.3600	36802.3000	81621.8300	13990.7900	6085.1000	79633.8400	42269.6900	18323.2300	7676.6900	155728.9200	21623.2300	72329.1200	9259.3600	9524.6500	66846.6100		62385.9100	45076.3600	40033.5700	30001.1500	24414.2400	25621.7600	19873.8900	1641.9000	19993.2200	8907.5500	91884.2100	45470.1700	662083.4400	143137.8300	27136.3200	21500.4300	16700.4900	7838.4900	53584.1200	10500.9100	4804.3300	16472.5900	16184.4500	8889.3500		14121.8700	31034.5200	58262.4800	96755.3400	136690.9200	11292.2600	117387.5000
Glycocholic acid	11655.1700	10530.9800	8078.6900	7574.6300	6006.4300	5050.7000	112549.1800	6511.4000	24502.9900	24089.1800	19206.5700	5691.3800	40450.3800	8672.8500	9735.6600	12205.3400	24502.9100	9016.9800	5110.0200	9583.8300	16627.0600	6784.5200	798.5100	26908.5500	8550.6300	24940.7800	12023.2200	7658.9800	13578.8500	1804.8100	24800.4400	12434.7000	12689.8300	23668.1500	15058.8900	7766.9300	3306.0500	2365.6600	3315.5300	3679.8200	17569.6500	21947.9900	188507.9200	80014.0200	5463.9700	7395.1700	9085.7100	9236.8300	25531.7400	16507.6300	9759.1700	7288.3500	5934.2300	5224.4000	1003.9400	3347.8000	23577.3100	27327.6200	82939.9700	37633.5100	5100.4200	16099.5500
Glycodeoxycholic acid	1340.8600	2857.0900	10163.3900	7591.4500	7123.8900	16083.2100	88380.5900	9316.7600	5972.8000	67049.1600	8397.2400	10440.3100	34048.4100	17102.1700	12325.0800	8620.9300	13799.4100	6361.5600	3087.9700	86585.0600	5408.5200	10805.3000	4715.5000	58561.1000	4609.1800	15283.1500	7115.3300	3807.4700	61328.2700	977.0500	5549.2800	18657.0100	1935.1900	6716.6600	4661.8800	20176.9700	12194.2700		8456.2900	4596.0000	66615.4900	12007.0200	231904.0000	37280.3200	11301.3300	6497.4400	8664.2200	1356.5800	5503.4000	4073.1200	1518.1600	5596.8300	12674.6900	1064.7700		5086.8600	8968.4200	9175.6300	52369.0400	96000.1500	3987.6700	54713.7800
Glycolithocholic acid																										989.9300			750.7500														8135.3500																			
Glycoursodeoxycholic acid			900.0400	744.3300	1175.6800	3528.2100	10811.2100			19223.9200	5024.5800	8444.4000	20765.4600	12266.9200	2185.1000	10780.1200	5952.0300			7002.9500	1899.8100	1181.5000		24474.7400	862.3600	4363.8600		1982.6100	7473.2500		3526.6100	6893.2100	7139.7400		1024.3200		2949.9300	901.3300	2282.8100		6908.6100	1060.3200	86828.4600	29738.0200	2943.5700	5220.3500	5844.4000	784.4100	9498.2400			2990.1900		979.4800		3546.2600	4449.9000	1146.2100	5220.6800	11784.9100	6369.4400	43641.0700
Heptadecanoic Acid		2863.3700	6774.0200		2150.0700	3136.1800	1920.1200	1330.2200	2949.7800	12681.5700	5156.9800	2607.2600	26444.5500	2832.8000	2224.5200				2956.9600	2777.2300	3359.8100	37155.8900	2055.3700		3553.8600		5222.3200					10558.1100	2327.5000		2680.0600			2587.7200	3236.0800	3467.3700	20931.3000		10768.0600		24176.5200		5590.1500			2611.3900		2146.4300	2766.7500	2757.5500	2843.3400		1460.0400	13024.9700	4171.1200	3500.5200	2770.9500	2883.3800
Lauric Acid	28913.9700	24614.5400	12940.7000	34022.9100	27073.9600	36306.6700	25860.7000	13086.5100	36201.8600	35059.0700	15239.5600	22997.8000	15363.6600	36991.1900	16238.0400	20808.0200	25109.1200	21852.2000	14322.4100	18614.9800	32621.4000	32347.1500	36638.7300	39193.4600	21899.7200	28492.4900	27104.3200	19998.3000	29158.0500	28486.4400	36772.9700	43663.3200	10159.0100	14926.5500	11190.8300	21972.2600	12258.5100	36221.4000	28179.9600	10631.7900	34728.8600	42869.5000	37417.5700	18945.5100	22986.3000	21202.1300	34851.6200	14902.2600	17444.9000	11759.4100	28609.2300	29443.7600	10573.7200	18433.2700	25800.8900	19537.6500	23732.6300	25425.3000	27126.9200	33146.8400	17488.6600	43197.6300
Leukotriene B4	1582.6800	1670.5300	13446.8900	2109.5600	2118.7300	4395.2700	1617.5300	2153.8800	1164.1400	4744.7700	1240.5300	4594.7400	2466.6200	2431.1300	9230.4000	1558.5900	3157.6900	1991.5500	9853.1600	5829.1900	3346.7300	4886.9000	2582.8000	4512.4200		1302.4200	8565.8300	3941.3700	4417.1100	7483.8900	3278.5900	2459.4200	4030.5900	4327.8300	1037.8600	3928.0100	4337.0500	5544.7600	5248.8800	1499.1400	4553.0200	2032.4100	4671.5500	1560.9900	2910.2800	7159.1200	9686.3600	1600.4300	4988.6600	3395.6900	3295.5100	1571.5700	7833.6000	1392.9900	1761.0700	5419.6200	6234.7200	1397.0600	3270.3800	3375.2600	8294.5000	13193.7100
Linoleic Acid	20234.6300	7391.2100	21910.6700	10084.9200	9302.2500	15250.8700	8361.1700	6134.9300	9750.4400	9854.1700	18598.8700	4841.1900	90065.6200	8622.7900	6031.7100	3279.3200	301251.9100	3879.8800	5989.1900	3742.2000	5897.9800	41747.9900	47009.8200	179062.5500	50930.0600	7980.9800	35403.8300	10691.9700	10459.2900	5589.8600	8879.3500	46574.3300	7194.1700	23862.4200	1261.3600	28954.6300	17875.1700	5031.6300	9715.2600	3036.6600	14881.4000	12424.4800	92728.9100	158279.1400	62257.3800	4871.0300	22375.2600	14091.2300	16648.3300	6376.2000	2611.4700	7852.5600	12897.1200	6681.2500	5021.4700	6342.0700	5931.6400	10623.9800	16019.5200	17246.9300	7920.2900	85611.1600
Myristic Acid	85483.8700	87502.8800	111651.9600	76701.2300	109643.5600	118535.0500	78058.7700	83084.6800	80232.4100	89376.1200	79981.7300	96677.6200	115273.1200	83924.0500	91864.1200	91640.4100	114752.3500	80787.4100	97665.6200	85548.8400	99493.5400	102247.9600	99776.3100	127687.4100	87122.5400	90837.9700	101637.9100	86528.4100	89748.7800	96471.2100	101364.9000	119961.5000	82890.9100	105974.4900	102264.0200	115575.6200	103516.0600	102573.8800	53060.6700	80444.4100	94479.7500	96261.2700	98140.2700	90827.7600	96123.0600	94775.3700	115648.7900	66811.8400	83205.0300	80334.8800	80701.0400	97665.2300	85021.7100	81477.8100	98956.9400	115070.5400	87517.5700	95489.5900	80166.9800	75829.9800	105335.1900	127728.4100
Oleic Acid	21602.8900	16270.1900	94991.7900	28110.4600	21510.5000	95721.0100	46071.1600	14583.2100	39966.3000	95790.8500	51776.9200	47613.9800	378320.6600	24634.2200	23076.8700	24143.2700	536161.1900	23454.3900	44699.2500	19822.3000	34200.0700	382819.1200	57677.6400	450088.7500	42068.2900	38582.3800	63241.1800	34570.1400	43562.2000	34044.5800	38550.2600	172897.8800	27439.3500	41622.9100	7710.2300	67100.9100	47222.5900	34086.8900	51473.2100	44434.0200	173993.4400	41571.2200	412218.6600	145618.9400	607954.0600	39828.2100	77585.3200	13550.3300	19466.0700	29175.4900	10665.6800	27547.3200	38571.1500	31230.9600	51224.5900	31856.7900	18352.9500	66596.1600	49841.3600	49194.0700	28939.6600	83102.0700
Palmitelaidic Acid	46730.0500	124673.6800	167994.4400	216370.3100	226853.3900	205777.3900	68717.9800	53768.5600	91737.1500	103088.1200	93895.6500	288252.9100	379768.2500	59422.3000	140799.4400	109942.5200	235709.5800	75566.1600	300803.9100	81442.7200	123257.0200	118536.6300	138680.4700	343128.9100	62265.8300	105240.4800	579549.8100	250513.8600	197889.0200	65540.8800	76705.1300	340553.5000	79606.7900	200156.8800	17306.1900	712261.0600	318221.7500	251524.2000	97695.7600	85657.4200	192673.3600	95298.1300	103587.8400	152690.2000	90833.9100	423966.9100	420262.0000	50176.4100	65360.9100	70133.6100	44233.4500	113575.4900	101277.5100	36285.3800	217930.8300	240513.6700	53732.6700	126592.2300	199325.6400	105916.5900	69979.2800	326610.5000
Palmitic Acid	60313.3900	92748.6200	333357.2200	110154.1900	97194.4600	426743.6600	338461.6600	73693.6600	201779.1900	709860.7500	235525.8300	273640.6600	1106212.0000	148847.6100	112556.1600	118648.7500	146448.2300	117493.4700	151503.6400	90545.5900	204784.5000	2233815.0000	115181.0000	265904.2800	84470.4500	195990.9400	146479.2800	139773.2800	157541.1700	181368.8000	170817.3900	563508.9400	100204.3800	151218.9400	52646.0800	228957.3000	189002.1400	160170.6700	192125.4500	266312.0900	1184152.8800	267611.5300	591682.6900	92773.1200	2302406.7500	73604.0900	240078.8100	79047.0800	92294.8200	122948.6600	95946.2900	119300.7400	238409.8600	278802.7800	307212.1600	117222.9300	95927.3800	415082.9100	175259.7700	214774.4400	184738.0500	157728.5300
Pentadecanoic Acid	26187.8800	44003.4300	69563.6500	69384.8800	26598.5000	71547.7300	57654.5000	20276.2300	83940.6200	78887.4100	78444.4100	80798.3000	153697.4100	44290.1600	40941.0500	18598.2300	25483.3300	41499.4100	20298.0100	20401.9700	67709.1300	82018.4800	60843.7000	79241.5000	30915.4900	51334.9300	91310.6200	53580.0000	24329.1300	48035.3800	66938.4500	115028.0400	27194.7800	26479.3800	19186.4300	59980.3300	49067.4100	50256.4300	84369.6600	27266.8900	89334.7300	61798.1800	36638.4500	32007.7900	85120.1700	41572.7200	50929.6100	42978.4000	18592.4000	26418.9200	17858.6400	33650.3600	25449.5500	27337.1000	20632.7800	83895.9500	91339.7800	111344.0600	65536.2100	71349.7700	58216.5000	79776.5600
Prostaglandin A2/B2			14803.0200													2703.2400										2801.3100	2558.3100							9905.1300																			3112.3900			3879.2400						5358.6600
Prostaglandin D2		1097.0800	2235.4900	1312.8100	1002.1700	873.9400	1025.2500	1913.6500			1127.2800	1951.9700	1476.2000	2308.4400	2189.4700	830.5300	4337.3800		1012.8100		856.7500	1129.4200	905.4300	892.1300	982.6100	748.6300	1270.0800	1756.8300	809.3800	1764.9900		1370.7400	1168.7900		1206.6000	2114.6500		1223.4800				1067.3700	973.6300	855.4100	939.9800	1310.4300	986.8200			1084.4000			590.0800	981.6500	955.6300	2351.2600	857.9000				1188.4600	1696.1700
Prostaglandin E2	1780.0200		1205.4600			798.1800		1054.9500	701.0700	2144.5200	687.6800	999.6100	880.7400	2308.4400	856.3100	1627.4900	1196.4800	1005.1900	2102.6500	1725.9900		944.6900	771.3000	1790.7600			755.0200	801.6500	2083.4400	2185.3800	746.1700		1087.8100	1556.2000	946.9400	1553.6100	3336.8500	1133.1800	897.0300	888.3200	2120.1800	1030.2600		871.3500	859.0100	2589.7100				745.6200		904.8800	681.2900	869.7100	1013.6400	778.4200		950.3400		836.3500	941.2100	1444.2400
Prostaglandin F2a/11b-Prostaglandin F2a/Prostaglandin E1/(±)5-iPF2a-VI	680.6600		1173.1600		2070.8600	1292.2200	935.4500	1130.0000	884.9700	1311.3300	1945.1600	1432.8900	3450.0900	1331.0500	1930.8800	1318.5400	1715.7600		1263.0000	2324.7300	927.7900	2476.3600		2285.5700	1059.3400	3056.2400	1162.6100	2372.6300	1091.1700	1083.6100	1135.0900	1353.6000	1281.9000	1149.7300	1610.1600	2059.4400		2972.4100	2029.5000	1181.3500	2172.3800	941.7200	911.8700	1891.6900	925.9100	880.3700	1557.5900	1102.3000	2531.7300	929.6700	1006.8900		1811.4800	1328.1400	991.2300	1194.8600	1164.9400	850.2500	787.2400	1196.6800	904.2000	1164.4800
Stearic Acid	79172.9300	92376.5000	99308.0900	93349.9600	81573.5800	121967.5600	81888.5900	110561.0600	71769.0500	168021.1200	85871.0900	70800.4500	230049.6200	90077.8100	129052.9100	76667.6900	76290.9600	69307.2500	136437.9800	99952.0300	93137.0000	277836.5900	80231.7100	96002.1600	82885.0600	72663.0400	133168.3900	79979.2900	77642.4400	97788.0400	103820.6000	114489.9500	107866.4000	114100.4800	321176.1600	70851.8000	136413.8300	68356.9600	53906.3600	69381.1800	173171.1200	70546.0600	104526.6200	101226.7300	270672.7800	261962.8300	132989.4500	94355.7000	78033.0600	86931.7500	68963.2300	69479.5800	49547.0900	92810.8400	81015.0500	95759.4100	81898.7600	114102.7500	120639.3000	72659.6400	83667.2500	110544.4400
Taurochenodeoxycholic acid					2785.7000		11795.9200	1776.1900	5355.2900	35060.2200	5867.2100		15688.1700	1365.2400		3535.0700	28548.7900	2461.8200		3645.0300	2857.2600			15594.2900		6696.9400			9257.1400		9966.1200	2653.9800	2762.3400		6546.0500						5936.7400	6641.8600	105045.1500	13171.3800	2026.2000	1090.3900			1923.7000		1091.3900					1119.8800		6280.9300	27604.0200	11831.6000		9136.2100
Taurocholic acid	2188.0400		2008.8000		1808.3700	791.3800	25942.7200		8812.9400	14376.2100	7533.3500		12519.8700	3635.6200	1940.3600	1014.1800	14121.8600	5035.1000	1975.3000	2939.3600	8359.0500		852.8900	2636.6600	2078.5000	5001.3300	6952.6800	2155.9200	7068.7700	1000.8900	12454.4500	5325.7900	3127.0200	10215.5100	6132.7000	2694.8900			934.1500		3255.8100	3931.7700	96748.7000	11841.4400	2247.7800				3057.0700	4520.2300	5802.3900	2479.3900	3824.8800	2725.5300		1302.1300	2780.9200	6900.0000	51056.6800	8829.5900		1125.7500
Taurodeoxycholic acid				2939.3600			4834.9800			26005.8900										9003.6700				4843.4300					7375.3600												4237.7900		61980.9700								3304.2200								18962.3800	11250.7100		4369.9500
Taurolithocholic acid																																																														
Tauroursodeoxycholic acid										1506.9800																																	4650.6200	849.4900																		
Ursodeoxycholic acid			5801.3700	1405.7400	2011.8800	7006.3000	9620.9800	1604.2000	2186.0800	17417.0000	12151.5300	7546.0800	16155.0100	14135.1000	2096.2400	15401.9000		8879.4000		29394.8000	2905.8900	7367.7700	2338.8900	31157.9600	2422.7800	1610.6900	1349.6800	6622.1200	12325.1400		8206.8100	5556.3300	13711.9700	1935.1000	1395.5500	5730.8300	8550.6400		2326.9700		36246.3200	1753.6100	37370.3000	17309.7700	5859.4200	6884.7500	10821.7700		8756.4400				11902.4500	1449.6500		1601.0400	1937.1300			58511.4700	5077.3400	18206.5300
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	pubchem_id	inchi_key	kegg_id	other_id	other_id_type	ri	ri_type	moverz_quant	
12(13)-DiHOME									
12(S)-HETE									
13-14-dihydro-15-keto Prostaglandin D2									
13-OxoODE									
13(S)-HODE									
15(S)-HEPE									
15(S)-HETE									
17(S)-HDHA									
5(S)-HETE									
9(10)-DiHOME									
9-OxoODE									
9(S)-HODE									
a-Linolenic Acid									
Arachidic Acid									
Arachidonic Acid									
Chenodeoxycholic acid									
Cholic acid									
Decanoic Acid									
Deoxycholic acid									
Dihomo-y-Linolenic Acid									
Docosahexaenoic Acid									
Docosapentaenoic Acid									
Eicosapentaenoic Acid									
Glycochenodeoxycholic acid									
Glycocholic acid									
Glycodeoxycholic acid									
Glycolithocholic acid									
Glycoursodeoxycholic acid									
Heptadecanoic Acid									
Lauric Acid									
Leukotriene B4									
Linoleic Acid									
Myristic Acid									
Oleic Acid									
Palmitelaidic Acid									
Palmitic Acid									
Pentadecanoic Acid									
Prostaglandin A2/B2									
Prostaglandin D2									
Prostaglandin E2									
Prostaglandin F2a/11b-Prostaglandin F2a/Prostaglandin E1/(±)5-iPF2a-VI									
Stearic Acid									
Taurochenodeoxycholic acid									
Taurocholic acid									
Taurodeoxycholic acid									
Taurolithocholic acid									
Tauroursodeoxycholic acid									
Ursodeoxycholic acid									
METABOLITES_END
#END